In our previous study, we have shown that deoxycoformycin (ADA1 and ADA2 inhibitor) counteracted BC-induced endothelial dysfunction, decreased 4T1 BC cell adhesion and transmigration through the endothelial cell layer, and suppressed migration and invasion of murine and human BC cells. Here, ADA is linked to breast cancer.